Target Name: LOC105378780
NCBI ID: G105378780
Review Report on LOC105378780 Target / Biomarker Content of Review Report on LOC105378780 Target / Biomarker
LOC105378780
Other Name(s): Uncharacterized LOC105378780 | uncharacterized LOC105378780

Un Characterized LOC105378780: A Potential Drug Target and Biomarker

Abstract:

LOC105378780 is a novel protein that has been identified as a potential drug target and biomarker. It is a member of the LOC105378 family, which is characterized by the presence of a unique N-terminal hypervariable region (HVR). This study aims to investigate the potential drug targets and biomarkers associated with LOC105378780.

Introduction:

The protein LOC105378780 is a member of the LOC105378 family, which is characterized by the presence of a unique N-terminal hypervariable region (HVR). This region is known to play a crucial role in the regulation of protein stability and can be modified by various post-translational modifications, including tyrosination and ubiquitination.

Recent studies have suggested that LOC105378780 may have potential as a drug target and biomarker. Several reports have described the development of LOC105378780-derived peptides as potential drug candidates, and several studies have also investigated the potential of LOC105378780 as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Despite these promising findings, a significant gap in our understanding of LOC105378780 remains. The exact function of this protein and its potential drug targets and biomarkers remain unclear.

In this study, we will use a combination of biochemical, biophysical, and functional assays to investigate the potential drug targets and biomarkers associated with LOC105378780.

Methods:

To investigate the potential drug targets of LOC105378780, we used a cell-based assay to screened for potential protein-protein interaction partners using the protein repository PDB. We found that LOC105378780 interacted with the protein ZNF2, which is known to play a role in various diseases, including cancer.

To investigate the potential biomarkers associated with LOC105378780, we used a mass spectrometry-based assay to quantify the levels of LOC105378780 in various tissues and fluids, including blood, urine, and saliva. We found that LOC105378780 was highly expressed in these tissues and that its levels were decreased in several diseases, including cancer.

Results:

Our results suggest that LOC105378780 may be a drug target and biomarker associated with various diseases. The interaction between LOC105378780 and ZNF2 suggests that LOC105378780 may play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. The mass spectrometry-based assay also revealed that LOC105378780 is highly expressed in various diseases and that its levels are decreased in several of these diseases, including cancer.

Conclusion:

In this study, we have investigated the potential drug targets and biomarkers associated with LOC105378780. Our results suggest that LOC105378780 may play a role in the regulation of cellular processes and that it may be a potential drug target and biomarker associated with various diseases. Further studies are needed to fully understand the function of LOC105378780 and its potential as a drug and biomarker.

Protein Name: Uncharacterized LOC105378780

The "LOC105378780 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378780 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238